HBM Healthcare Investments AG Stock
Stocks
HBMN
CH0012627250
Investment Management & Fund Operators
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 249.50 CHF | +0.20% |
|
+2.25% | +10.15% |
| 07-07 | Fore Biotherapeutics Inc. announced that it has received $110 million in funding from a group of investors | CI |
| 07-02 | HBM Healthcare Investments Expects CHF238 Million Profit for Fiscal Q1 | MT |
| Market Cap | 1.65B 2.05B 1.79B 1.52B 2.89B 195B 2.94B 19.72B 7.74B 96.11B 7.68B 7.51B 330B | P/E 2025 |
66.4x | P/E 2026 | 5.52x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74B 2.16B 1.89B 1.61B 3.06B 206B 3.11B 20.85B 8.19B 102B 8.12B 7.94B 349B | EV / Sales 2025 |
59.3x | EV / Sales 2026 | 5.76x |
| Free-Float |
81.5% | Yield 2025 |
4.14% | Yield 2026 | 4% |
| 1 day | +0.20% | ||
| 1 week | +2.25% | ||
| Current month | +5.72% | ||
| 1 month | +7.08% | ||
| 3 months | +8.24% | ||
| 6 months | +5.05% | ||
| Current year | +10.15% |
| 1 week | 237 | 258 | |
| 1 month | 227.5 | 258 | |
| Current year | 199 | 258 | |
| 1 year | 158 | 258 | |
| 3 years | 135.2 | 258 | |
| 5 years | 135.2 | 367 | |
| 10 years | 91.85 | 367 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 66 | 20/02/2012 |
Erwin Troxler
DFI | Director of Finance/CFO | 56 | 01/11/2011 |
Thomas Heimann
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 01/06/2009 | |
Rudolf Lanz
BRD | Director/Board Member | 76 | 01/01/2003 |
Mario Giuliani
BRD | Director/Board Member | 54 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-01 | Buy | 467 | 0.0069% | |||
| 04-01 | Buy | 467 | 0.0069% | |||
| 04-01 | Buy | 467 | 0.0069% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.20% | +2.25% | +56.33% | +28.48% | 2.05B | ||
| -1.75% | -0.39% | +60.38% | +24.78% | 3.46B | ||
| +2.04% | +0.31% | -14.57% | +4.64% | 2.95B | ||
| +0.91% | +2.96% | +73.94% | +135.87% | 1.29B | ||
| 0.00% | 0.00% | -1.72% | -7.02% | 723M | ||
| +10.56% | -8.06% | +133.52% | +225.20% | 589M | ||
| 0.00% | 0.00% | -4.67% | -8.33% | 400M | ||
| 0.00% | 0.00% | -47.76% | -75.18% | 387M | ||
| 0.00% | 0.00% | -1.83% | -12.24% | 376M | ||
| 0.00% | 0.00% | -4.38% | -10.27% | 361M | ||
| Average | +1.20% | -0.13% | +24.93% | +30.59% | 1.26B | |
| Weighted average by Cap. | +0.62% | -0.04% | +34.28% | +33.38% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 22.32M 27.67M 24.2M 20.62M 39.12M 2.64B 39.78M 267M 105M 1.3B 104M 102M 4.47B | 276M 342M 299M 255M 483M 32.6B 491M 3.29B 1.29B 16.06B 1.28B 1.26B 55.21B |
| Net income | 18.54M 22.98M 20.1M 17.13M 32.49M 2.19B 33.04M 222M 87M 1.08B 86.29M 84.41M 3.71B | 272M 337M 295M 251M 476M 32.14B 484M 3.25B 1.28B 15.83B 1.27B 1.24B 54.43B |
| Net Debt | 97.09M 120M 105M 89.68M 170M 11.48B 173M 1.16B 456M 5.65B 452M 442M 19.44B | 94.33M 117M 102M 87.12M 165M 11.15B 168M 1.13B 443M 5.49B 439M 429M 18.89B |
Employees
700
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | CHF 249.50 | +0.20% | 1,552 |
| 09/07/26 | CHF 249.00 | -1.19% | 6,763 |
| 08/07/26 | CHF 252.00 | -1.37% | 4,650 |
| 07/07/26 | CHF 255.50 | +5.14% | 18,325 |
| 06/07/26 | CHF 243.00 | -0.41% | 9,423 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
249.50CHF
Average target price
280.00CHF
Spread / Average Target
+12.22%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HBMN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















